LAKE OSWEGO, Ore., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will provide a presentation entitled, “Cancer Vaccine Development Strategies” at The World Cancer Immunotherapy Conference. The presentation will take place on Wednesday, January 25, 2012 at 9:40 am PST at the Hilton San Diego Gaslamp Quarter in San Diego, CA.
